Caption
Researcher, Steve Gentleman, holds up a slide showing brain tissue
Survey shows a lack of awareness of brain donation for research
Date
Research news
Caption
Researcher, Steve Gentleman, holds up a slide showing brain tissue
Survey shows a lack of awareness of brain donation for research
Date
Our survey of 2,000 UK adults shows that research is at risk due to a lack of awareness surrounding brain donation.
Cannabis extract may hold key to stop pain in Parkinson's
Date
Cannabis-based compounds could be the silver bullet to relieve pain for people with Parkinson’s according to the largest ever study into pain and the condition.
Potential treatment for dyskinesia in Parkinson’s
Date
Results from a one-year project, funded through the Parkinson’s Virtual Biotech, suggest that NLX-112 has potential as a future treatment for reducing dyskinesia and improving movement symptoms of Parkinson’s.
Initial results from CDNF clinical trial announced
Date
Herantis Pharma has published initial results from a phase 1/2 study of an experimental protective protein called CDNF which may hold potential to slow, stop or reverse Parkinson's.
GDNF - where are we one year on?
Date
GDNF clinical trial results in 2019 revealed signs that GDNF may make it possible to repair the cells damaged in people with Parkinson’s. We take a look at where we are one year later.
BT13 molecule offers hope for halting Parkinson’s
Date
A promising molecule, called BT13, has offered hope for a new treatment that could stop or slow Parkinson’s, something no treatment can currently do.
Gut bacteria could guard against Parkinson’s
Date
New research suggests that a bacteria which boosts digestive health can slow – and even reverse – the build-up of a protein associated with Parkinson’s.
Poll finds a quarter of people with Parkinson’s are wrongly diagnosed
Date
In our survey of more than 2,000 people, more than a quarter (26%) reported they were misdiagnosed with a different condition before receiving the correct Parkinson’s diagnosis.
Full results of repurposed cancer drug trial highlight potential benefits
Date
Previous top line results indicated that, while safe, Nilotinib failed to show benefit. The full results now show that there may be some potential benefits.
8 remarkable things we achieved together in 2019, and recent years
Date
2019 was another exciting year of progress. Here are 8 of the highlights, and 8 ways you can still get involved.